UNSPSC 51431702: Benazeprilat

This classification denotes an ace inhibitor with the molecular formula C22H24N2O5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier JRM708L703, chemically known as 1h-1-benzazepine-1-acetic acid, 3-(((1s)-1-carboxy-3-phenylpropyl)amino)-2,3,4,5-tetrahydro-2-oxo-, (3s)- but generally known as benazeprilat, which bears US NIH Compound Identifier 5463984. European Medicines Agency schedules Benazeprilat in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05701MIG.

UNSPSC 51431702 Benazeprilat is a Commodity code capturing emergency-response medications—specifically injectable cardiac and vasopressor agents—procured by fire and emergency medical services departments. The work solicited under this code involves supplying Advanced Life Support medications in bulk quantities to municipal fire rescue operations, with strict requirements for stability, delivery speed, and regulatory compliance including OSHA Safety Data Sheets and accessibility documentation.

The City of Tampa's Purchasing Department posted an IFB (Bid No. 26P00188) on April 24, 2026, for Advanced Life Support Medications to supply Tampa Fire Rescue in Hillsborough County, Florida, with an estimated contract value of $40,000.00 and a response deadline of April 8, 2026. The solicitation called for four medication line items totaling 3,530 units (Labetalol HCI 100mg vials, Epinephrine 1:10,000 injections, Adenosine 6mg vials, and Diltiazem 25mg vials), with nine-month minimum shelf life from acceptance, ten-day delivery, and a one-year initial term plus up to three additional one-year renewal options. The bid included a Small Local Business Enterprise sheltered-market set-aside with a 5 percent discount capped at $10,000. Recent activity under this code appears limited to fire and EMS supply procurement in Florida, with no additional opportunities documented in the source.